Common Side Effects When side effects occurred, they were typically mild, transient, and similar in frequency to placebo groups: Reported Adverse Effects Most Common (occurring in small percentage of participants): Mild to moderate headaches (most frequently reported, often resolving with continued use) Injection site reactions (minor redness, swelling, or irritation at injection site) Gastrointestinal effects (particularly at higher oral doses: mild nausea, diarrhea, flatulence) Fatigue (reported occasionally during initial adaptation period) Rare Events: One case of chest tightness was deemed possibly related to treatment in safety trials
(4) The intervention involved any Glucagon-like peptide-1 receptor agonist (GLP-1 RA)
Psoriasis is not so rare - the latest data shows over 100,000 hospitals cases
(97), have developed SLNs co-loaded with dopamine for intranasal administration, which offers a multifunctional approach to PD treatment
While direct human trials on the combination for cognition are sparse, the mechanistic synergy supports potential for addressing mitochondrial dysfunction in age-related cognitive decline [5]
The influence of a novel antiulcer peptide, BPC-157, on the healing of the rat skin and muscle wounds
